Skip to content

Twitter page opens in new window Linkedin page opens in new window Instagram page opens in new window

info@pharmaust.com+61 8 9202 6814

PharmAust (PAA)

HOME
ABOUT
PIPELINE & TRIALS
INVESTOR CENTRE
MEDIA
CONTACT

HOME
ABOUT
PIPELINE & TRIALS
INVESTOR CENTRE
MEDIA
CONTACT

Top 20 Shareholders 14 December 2018

Top_Holders_Report (14)Download

Category: News & Announcements 2018By Richard Mollard December 17, 2018

Related posts

Top 20 Shareholders 30th December 2018
January 7, 2019

PharmAust Manufacturing Method Maintains Drug Potency
December 2, 2018

GMP Tablet Production for Clinical Trials Commences
November 13, 2018

2018 AGM Results
November 9, 2018

2018 AGM Presentation
November 9, 2018

Top 20 Shareholders 31st October 2018
November 6, 2018

Recent Articles

April 30, Top 20 Shareholders
May 1, 2021
April 29, Appendix 4C and Quarterly Update
April 29, 2021
April 27, Monepantel Phase IIb Dog Lymphoma Interim Plasma Data
April 27, 2021
April 8, PharmAust Receives $750k R&D Tax Incentive Refund
April 8, 2021

MENU

Home
About Us
Pipeline & Trials
Investor Centre
Media
Contact Us

SUBSCRIBE TO OUR NEWSLETTER

Leave this field empty if you're human:

TWITTER

PharmAustFollow

PharmAust @PharmAust·

$PAA/@PharmAust is thankful to @FightMND and the #BigFreeze for funding our upcoming Motor Neurone Disease Phase 1 human trial

#PlayOn #BF2021 #FightMND
#BigFreeze7 #PlayOnBF7 💙

https://www.businessnews.com.au/article/PharmAust-clinches-funding-for-Motor-Neurone-Disease-trial

Reply on Twitter 1392992351862198276 Retweet on Twitter 1392992351862198276 Like on Twitter 1392992351862198276 Twitter 1392992351862198276

Copyright © 2020 Pharmaust. All rights reserved.

Website Design & Digital Marketing Perth by Total Click Solutions